Vida Ventures, Boston ’s newest healthcare VC firm, unveils $255M fund

According to a federal filing, executives at the firm include former Kite Pharma CEO Arie Belldegrun, who orchestrated the California biotech ’s $12 billion sale to Gilead Sciences earlier this year.
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news